AA & Approval are imminent, no other reason for FDA to ask for data.
The only reason the FDA is asking for this information is because AA and approval are imminent. If the FDA wasn't going to grant AA/approval, then there would be absolutely no need to request this additional data. They would have simply said that there wasn't enough information to grant AA, or the trial size was too small, or something else.
The AA will happen imminently, and approval will too, both in 2013.
yep. This was classic confusion due to the primary event not looking like what investors thought, but the news is great. This type of day is why money can be made in the markets - emotions and opportunity.